Riverhead Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $638K | Buy |
|
|||||
|
2019
Q2 | $749K | Sell |
|
|||||
|
2019
Q1 | $1.17M | Buy |
|
|||||
|
2018
Q4 | $638K | Buy |
|
|||||
|
2018
Q3 | $900K | Buy |
|
|||||
|
2018
Q2 | $791K | Buy |
|
|||||
|
2018
Q1 | $642K | Sell |
|
|||||
|
2017
Q4 | $705K | Buy |
|
|||||
|
2017
Q3 | $655K | Sell |
|
|||||
|
2017
Q2 | $653K | Buy |
|
|||||
|
2017
Q1 | $602K | Buy |
|
|||||
|
2016
Q4 | $510K | Sell |
|
|||||
|
2016
Q3 | $584K | Sell |
|
|||||
|
2016
Q2 | $872K | Buy |
|
|||||
|
2016
Q1 | $2.46M | Sell |
|
|||||
|
2015
Q4 | $5.04M | Buy |
|
|||||
|
2015
Q3 | $4.04M | Sell |
|
|||||
|
2015
Q2 | $4.93M | Buy |
|
|||||
|
2015
Q1 | $4.49M | Buy |
|
|||||
|
2014
Q4 | $4.66M | Sell |
|
|||||
|
2014
Q3 | $4.21M | Buy |
|
|||||
|
2014
Q2 | $3.54M | Buy |
|
|||||
|
2014
Q1 | $2.83M | Buy |
|
|||||
|
2013
Q4 | $2.37M | Buy |
|
|||||
|
2013
Q3 | $1.28M | Hold |
|
|||||
|
2013
Q2 | $1.01M | Buy |
|